731 filings
Page 4 of 37
8-K
PLX
Protalix BioTherapeutics Inc.
1 Sep 22
Entry into a Material Definitive Agreement
4:31pm
10-Q
2022 Q2
PLX
Protalix BioTherapeutics Inc.
Quarterly report
15 Aug 22
7:09am
8-K
PLX
Protalix BioTherapeutics Inc.
15 Aug 22
Protalix BioTherapeutics Reports Second Quarter 2022 Financial and Business Results
7:04am
S-8
PLX
Protalix BioTherapeutics Inc.
14 Jul 22
Registration of securities for employees
4:31pm
4
Zvi Shmuel Ben
5 Jul 22
Protalix BioTherapeutics / Zvi Shmuel Ben ownership change
4:32pm
3
PLX
Protalix BioTherapeutics Inc.
5 Jul 22
Protalix BioTherapeutics / Zvi Shmuel Ben ownership change
4:30pm
8-K
PLX
Protalix BioTherapeutics Inc.
30 Jun 22
Protalix BioTherapeutics Appoints Shmuel “Muli” Ben Zvi, Ph.D. to its Board of Directors
5:10pm
UPLOAD
PLX
Protalix BioTherapeutics Inc.
30 Jun 22
Letter from SEC
12:00am
CORRESP
PLX
Protalix BioTherapeutics Inc.
29 Jun 22
Correspondence with SEC
12:00am
UPLOAD
PLX
Protalix BioTherapeutics Inc.
23 Jun 22
Letter from SEC
12:00am
DEFA14A
PLX
Protalix BioTherapeutics Inc.
16 Jun 22
Additional proxy soliciting materials
4:30pm
SC 13G
PLX
Protalix BioTherapeutics Inc.
9 Jun 22
Protalix BioTherapeutics / WHITEBOX ADVISORS ownership change
2:52pm
8-K
PLX
Protalix BioTherapeutics Inc.
26 May 22
Regulation FD Disclosure
4:39pm
10-Q
2022 Q1
PLX
Protalix BioTherapeutics Inc.
Quarterly report
16 May 22
7:09am
8-K
PLX
Protalix BioTherapeutics Inc.
16 May 22
Protalix BioTherapeutics Reports First Quarter 2022 Financial and Business Results
7:00am
8-K
PLX
Protalix BioTherapeutics Inc.
2 May 22
Entry into a Material Definitive Agreement
6:24am
424B5
PLX
Protalix BioTherapeutics Inc.
2 May 22
Prospectus supplement for primary offering
6:05am
EFFECT
PLX
Protalix BioTherapeutics Inc.
2 May 22
Notice of effectiveness
12:15am
DEF 14A
PLX
Protalix BioTherapeutics Inc.
Definitive proxy
29 Apr 22
4:36pm
CORRESP
PLX
Protalix BioTherapeutics Inc.
27 Apr 22
Correspondence with SEC
12:00am